Greytown Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $1.75M | Buy |
12,740
+206
| +2% | +$28.3K | 1.03% | 20 |
|
2024
Q1 | $1.72M | Sell |
12,534
-448
| -3% | -$61.5K | 0.97% | 21 |
|
2023
Q4 | $1.76M | Sell |
12,982
-878
| -6% | -$119K | 0.94% | 20 |
|
2023
Q3 | $1.7M | Buy |
13,860
+696
| +5% | +$85.2K | 0.94% | 20 |
|
2023
Q2 | $1.67M | Sell |
13,164
-20,024
| -60% | -$2.54M | 0.91% | 19 |
|
2023
Q1 | $4.29M | Buy |
33,188
+634
| +2% | +$81.9K | 2.22% | 13 |
|
2022
Q4 | $4.27M | Buy |
32,554
+127
| +0.4% | +$16.7K | 2.32% | 12 |
|
2022
Q3 | $3.79M | Buy |
32,427
+9,539
| +42% | +$1.12M | 2.29% | 12 |
|
2022
Q2 | $2.69M | Buy |
22,888
+10,236
| +81% | +$1.2M | 1.53% | 16 |
|
2022
Q1 | $1.65M | Buy |
+12,652
| New | +$1.65M | 0.8% | 22 |
|